Dovitinib (TKI258) and Abiraterone Acetate in Metastatic Castrate-Resistant Prostate Cancer (mCRPC)

NCT01994590 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Sponsor stopped supplying study drug

Conditions

Prostate Cancer

Interventions

DRUG: Dovitinib
DRUG: Abiraterone Acetate
DRUG: Prednisone

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]